HomeCSCI • TSE
add
COSCIENS Biopharma Inc
Previous close
$3.29
Day range
$3.01 - $3.10
Year range
$2.85 - $6.46
Market cap
9.58M CAD
Avg Volume
2.29K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.48M | -20.74% |
Operating expense | 2.63M | -54.62% |
Net income | -1.82M | 68.39% |
Net profit margin | -122.66 | 60.12% |
Earnings per share | — | — |
EBITDA | -1.80M | 58.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.52M | -57.38% |
Total assets | 23.86M | -45.49% |
Total liabilities | 18.78M | -20.95% |
Total equity | 5.08M | — |
Shares outstanding | 3.18M | — |
Price to book | 2.06 | — |
Return on assets | -20.26% | — |
Return on capital | -62.72% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.82M | 68.39% |
Cash from operations | -676.00K | 91.31% |
Cash from investing | 4.00K | -95.18% |
Cash from financing | -85.00K | 54.79% |
Net change in cash | -809.00K | 89.64% |
Free cash flow | -801.75K | 88.22% |
About
Founded
1990
Headquarters
Website
Employees
40
